Moclobemide and selegeline in the treatment of depression in Parkinson's disease

Documenti analoghi

• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
  di: Anderson, K. E., et al.
  Pubblicazione: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages.
  di: MacMahon, D. G., et al.
  Pubblicazione: (1996)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline may be toxic in presence of increased dopamine concentrations.
  di: Yu, P. H., et al.
  Pubblicazione: (1996)
• Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
  di: Lapierre, Y D, et al.
  Pubblicazione: (1997)
• Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Parkinson's disease is rarely a primary cause of death.
  di: Silva, M. T., et al.
  Pubblicazione: (1996)